Search results
-
Dr Alejandra Bruna
We aimed to study the effects of the TGF-beta pathway in breast cancer stem cell (BCSC) regulation. To define a role of the TGF-beta pathway in the regulation of human BCSCs, we have analyzed a panel of breast cancer cell lines that represent the...
-
Dr Joanna Baxter
The Cambridge Blood and Stem Cell Biobank is a facility of over 6000 viable and nucleic acid samples, the majority from patients with haematological malignancy and clonal blood cell disorders; and the remainder, around 20%, from normal individuals,...
-
Professor Jean Abraham
-
-
Professor Duncan Jodrell
I endeavour to integrate and optimise the pre-clinical development and science-led clinical application of novel therapies and novel therapeutic combinations, including first into man (phase I) and associated studies. My research goal is to identify...
-
Dr Oscar M Rueda
Development of statistical methods and models for the analysis and integration of breast cancer high-throughput data: detection of alterations in DNA copy number and their influence in mRNA expression and survival, in order to obtain predictive markers....
-
Dr Richard Baird
Early phase clinical trials, including expertise in: ...
-
Dr Robin Hesketh
I am based in the Biochemistry Department and work on several cancer related projects, primarily in collaboration with Jim Metcalfe, Kevin Brindle and Doug Easton. These fall into four areas (1) Development of anti-angiogenic gene therapy, (2) Studies...